Cincinnati Cancer Advisors

Cincinnati Cancer Advisors CCA provides no-cost consultative oncology & genetic counseling services to Greater Cincinnati.

10/26/2025

Thank you for inviting us to be a part of Spooktacular Saturday! Don’t forget to support Element Eatery and CCA in October by “Sipping Pink” at the Garden Bar!

A cancer diagnosis can be scary, but getting a second opinion doesn’t have to be. Learn more about our expert, no-cost second opinions at CincinnatiCancerAdvisors.org.

ASCO Direct™ Best of Oncology Conference speaker spotlight: Mark Pegram, MDLearn more and register for our November 8th ...
10/22/2025

ASCO Direct™ Best of Oncology Conference speaker spotlight: Mark Pegram, MD

Learn more and register for our November 8th conference at the link in bio.

Bio: Mark Pegram, MD, is the Suzy Yuan-Huey Hung Endowed Professor of Medical Oncology at the Stanford University School of Medicine. He currently serves as the Associate Director of Clinical Research at the Stanford Comprehensive Cancer Institute (SCCI). He also serves as the Associate Dean for Clinical Research Quality at the Stanford University School of Medicine, and is the Medical Director of the Stanford Clinical Translational Research Unit – a unit specializing in first-in-human phase I clinical trials.

Dr Pegram received his medical degree from the University of North Carolina at Chapel Hill. He went on to complete an internship and residency at the University of Texas Southwestern Medical Center in Dallas. He concluded his training with a fellowship at the UCLA David Geffen School of Medicine in Los Angeles, CA.

Dr Pegram’s breast cancer research is focused on the study of the cancer-associated gene that encodes HER2 and on the development of novel agents in the treatment of patients with HER2-positive metastatic breast cancer. Dr Pegram has been educating other healthcare professionals about the future impact of biosimilars in oncology practice, especially in the breast cancer treatment landscape. He has authored more than 110 publications in medical oncology, hematology, and biosimilars across different cancer types.

ASCO Direct™ Best of Oncology Conference speaker spotlight: Alex Adjei MD, PhD, FACP, FASCOLearn more and register for o...
10/09/2025

ASCO Direct™ Best of Oncology Conference speaker spotlight: Alex Adjei MD, PhD, FACP, FASCO

Learn more and register for our November 8th conference here: https://ccabestofoncology.org/

Bio: Alex A. Adjei, MD, PhD, FACP, FASCO, is the Chief of the Cleveland Clinic Cancer Institute, overseeing cancer programs across Cleveland Clinic locations in Ohio, Florida, Abu Dhabi, and London. He is also the Director of the Taussig Cancer Center and holds a distinguished chair in Translational Cancer Research. Dr. Adjei has served on several US National Cancer Institute committees and is a member of the NCI Board of Scientific Counselors. He is editor-in-chief of the Journal of Thoracic Oncology and President-Elect of the International Association for the Study of Lung Cancer. His research focuses on experimental therapeutics and clinical drug development, with over 320 publications to his name.

This October, Element Eatery (EE) in Madison is turning pink! Throughout this month, $1 of each drink sale from the Ga...
10/09/2025

This October, Element Eatery (EE) in Madison is turning pink!

Throughout this month, $1 of each drink sale from the Garden Bar’s featured drink menu will benefit the Cincinnati Cancer Foundation. EE’s Natalie Kaufman created the initiative in honor of her mother, Gwen, a former CCA patient, who passed away from breast cancer in August 2025.

Sip a cocktail or mocktail, raise a glass, and join us in supporting local cancer patients. Thank you, Element Eatery. Cheers!

ASCO Direct™ Best of Oncology Conference speaker spotlight: Bilal Siddiqui, MDLearn more and register for our November 8...
10/01/2025

ASCO Direct™ Best of Oncology Conference speaker spotlight: Bilal Siddiqui, MD

Learn more and register for our November 8th conference here: https://ccabestofoncology.org/

Bio: Dr. Siddiqui is an Assistant Professor in Genitourinary Medical Oncology at the University of Texas MD Anderson. He is a clinical and translational investigator with a focus on:1) biomarker-rich trials of novel immunotherapy strategies in prostate cancer, with a special emphasis on T cell engagers; and 2) improving outcomes in immune-mediated toxicities through identification of mechanistic biomarkers for early detection and rational intervention. He serves as a principal investigator on multiple clinical trials of T cell engagers in prostate cancer, including leading multicenter sponsored trials and investigator-initiated studies. He is a member of the MD Anderson IOTOX Leaders’ Group, meeting a critical need as immunotherapy combinations with higher rates of toxicities are growing rapidly. He has a special interest in immune-mediated myocarditis and myositis, which carry a high mortality rate. His recent work identified a novel population of IL-1-expressing macrophages in human heart tissue from patients with immune-mediated myocarditis that represents a potential therapeutic target for which a rational clinical trial is under development. The long-term goals of this work is to maximize efficacy and minimize toxicities of these immunotherapy strategies in patients.

While our team was having its weekly Best of Oncology conference planning meeting during lunch today, we received a surp...
09/29/2025

While our team was having its weekly Best of Oncology conference planning meeting during lunch today, we received a surprise visit from Dr. Leming's wife, Tracy, along with a massive bag of cheesecake from The Cheesecake Factory.

When asked what the surprise desserts were for, Tracy replied, "It's Philip Leming Day in Cincinnati!"

We then discovered a framed proclamation on Dr. Leming's office wall of many certificates, which the mayor declared September 29, 2022, was indeed "Philip D. Leming, M.D. Day." However, our team will continue celebrating our beloved Medical Director on this day every year.

"I want people to be able to feel that we listened, that we genuinely care, and that we will use all resources that exist on the planet Earth to improve their prognosis, their care, their life, or just give them hope that they are not without the potential of a better day tomorrow." - Dr. Philip Leming

Thank you for everything you do, Dr. Leming, and happy Philip D. Leming Day to all who celebrate 🎉

serves as a call to action for a coordinated global effort, aiming to make cancer a manageable and ultimately curable ...
09/24/2025

serves as a call to action for a coordinated global effort, aiming to make cancer a manageable and ultimately curable disease for everyone.

In our pursuit of providing patients with access to the latest innovations in cancer care and research, we offer participation in select clinical research studies to those who are interested. We are proud to have clinical team members who not only hold credentials from leading oncology institutions but are also actively involved in educating care providers through national publications and other initiatives.

Learn more about the latest practice-changing data and other emerging topics from the 2025 ASCO Annual Meeting at our Best of Oncology highlights conference on November 8th: https://ccabestofoncology.org/

ASCO Direct™ Best of Oncology Conference speaker spotlight: Rami Komrokji, MDLearn more and register for our November 8t...
09/18/2025

ASCO Direct™ Best of Oncology Conference speaker spotlight: Rami Komrokji, MD

Learn more and register for our November 8th conference here: https://ccabestofoncology.org/

Bio: Dr. Komrokji is the Vice Chair of the Malignant Hematology Department at the Moffitt Cancer Center, Tampa, Florida.

He is a senior Member of the Malignant Hematology and Experimental Therapeutics Program at the Moffitt Cancer Center, and Professor in Medicine & Oncologic Sciences at the College of Medicine, at the University of South Florida in Tampa, Florida.

After earning a medical degree in 1996 from the Jordan University School of Medicine, Dr. Komrokji completed an internship and residency at Case Western University, St. Vincent Program. He then completed a fellowship at Strong Memorial Hospital, University of Rochester, in Hematology/Oncology and Hematopoietic Stem Cell Transplantation.

Dr Komrokji is expert in myeloid neoplasms where he led several clinical trials and lectured worldwide. His work paved the FDA approval for luspatercept in myelodysplastic syndromes and for Pacritinib in myelofibrosis.

He has authored or co-authored more than 380 peer-reviewed manuscripts, 20 book chapters, and more than 1000 abstracts in Hematologic Malignancies. He served as member on the MDS Panel of the National Comprehensive Cancer Network (NCCN) and currently member of the NHLBI MDS natural history study steering committee and aplastic anemia and MDS foundation medical board of directors. He was member of the editorial board for Journal of Clinical Oncology (JCO). He is peer reviewer for several medical journals including Blood Journal, JCO and Leukemia Journal. He is a regularly invited speaker at national and international meetings and had won several awards in recognition of his work.

Dr. Komrokji’s research interests are in Phase I and II Clinical Trials, and in the outcome research in hematologic malignancies with focus on myeloid neoplasms. His clinical interests are Myelodysplastic syndromes (MDS), Acute Myeloid Leukemias, and Myeloproliferative neoplasms.

On August 25th, we hosted our 5th Annual Steve Abbott Memorial Golf Classic. Today, in honor of Steve’s birthday, we’re ...
09/11/2025

On August 25th, we hosted our 5th Annual Steve Abbott Memorial Golf Classic. Today, in honor of Steve’s birthday, we’re especially proud to reflect on the incredible day we shared. 💙

Thank you to our sponsors, players, and volunteers who made this event such a success. Your support helps us continue Steve’s legacy in such a meaningful and impactful way.

We can’t wait to welcome everyone back next year for another amazing day at Clovernook Country Club! ⛳️

Thank you, Cincinnati Business Courier, for publishing an article written by Cincinnati Cancer Foundation (CCF) Executiv...
08/21/2025

Thank you, Cincinnati Business Courier, for publishing an article written by Cincinnati Cancer Foundation (CCF) Executive Director, Lana Uhrig, about our exciting and transformative partnership with RIDE CINCINNATI.

CCF's role in distributing Ride Cincinnati proceeds through a competitive grant process is more than a change in funding—it marks a shift in how we serve and show up for our community, expanding our ability to support more people across the cancer landscape.

Read more here: https://www.bizjournals.com/cincinnati/news/2025/08/19/ride-cincinnati-fueling-vision-cancer-care.html

Cincinnati Cancer Advisors (CCA) would like to thank all of our fantastic Birdie Sponsors for supporting the 2025 Steve ...
08/19/2025

Cincinnati Cancer Advisors (CCA) would like to thank all of our fantastic Birdie Sponsors for supporting the 2025 Steve Abbott Memorial Golf Classic! Thanks to these great sponsors, we are officially SOLD OUT for the 5th year in a row. 🥳

We look forward to seeing you on Monday!

World Breast Cancer Research Day is a time to honor the pioneers driving progress — and we’re proud to have one of them ...
08/18/2025

World Breast Cancer Research Day is a time to honor the pioneers driving progress — and we’re proud to have one of them on our team.

Robin Zon, MD, FACP, FASCO, brings decades of clinical expertise and national leadership to Cincinnati Cancer Advisors. As the Director of Breast Oncology and outgoing President of ASCO, Dr. Zon has helped shape the future of oncology care and research — including how telehealth improves access to expert guidance for breast cancer patients.

Her commitment to innovation and patient-centered care reflects everything we stand for at CCA: empowering individuals through knowledge, compassion, and cutting-edge cancer support.

We're honored to have her voice and vision as part of our mission.

Address

4805 Montgomery Road, Suite 130
Cincinnati, OH
45212

Opening Hours

Monday 8:30am - 4:30pm
Tuesday 8:30am - 4:30pm
Wednesday 8:30am - 4:30pm
Thursday 8:30am - 4:30pm
Friday 8:30am - 4:30pm

Telephone

+15137312273

Website

Alerts

Be the first to know and let us send you an email when Cincinnati Cancer Advisors posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cincinnati Cancer Advisors:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category